Patient-Reported Outcomes as End Points in Heart Failure Trials
- 15 April 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (15) , 1111-1125
Abstract
Heart failure is a growing health-care concern affecting tens of millions of individuals globally. Although traditional therapeutic strategies have focused on reducing the risk for hospitalization and mortality, the importance of patient-reported outcomes (PROs) in patients with heart failure is increasingly being recognized. Regulatory agencies consider PROs part of their evaluation of drugs and devices, and professional society guidelines may recommend interventions that improve PROs. However, for several reasons, the effect of interventions on PROs reported in heart failure trials currently is difficult to interpret. There is no consensus on the timing and frequency of PRO assessments. Moreover, it has been difficult to establish a minimal clinically important difference, that is, the minimal change in a PRO score that is meaningful to a patient. In addition, traditional methods of analyzing and reporting PROs such as comparison of mean differences across groups or responder analysis are prone to statistical artifacts and misinterpretation. This article presents an in-depth discussion of these issues, with the Kansas City Cardiomyopathy Questionnaire used as an example, to facilitate the use of PROs in heart failure research, regulatory, and clinical settings.Keywords
This publication has 53 references indexed in Scilit:
- Mechanical Dyssynchrony as a Selection Criterion for Cardiac Resynchronization Therapy: Design of the AMEND-CRT TrialESC Heart Failure, 2024
- Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection FractionJAMA, 2020
- Comparison of Patient Self-reported Health Status With Clinician-Assigned New York Heart Association ClassificationJAMA Network Open, 2020
- Rationale and Design of The Emperial-Preserved and Emperial-Reduced Trials of Empagliflozin in Patients with Chronic Heart FailureEuropean Journal of Heart Failure, 2019
- Relationship Between Changing Patient-Reported Outcomes and Subsequent Clinical Events in Patients with Chronic Heart Failure: Insights From HF-ACTIONEuropean Journal of Heart Failure, 2018
- Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection FractionJAMA Cardiology, 2017
- Quality of Life and Long-Term Mortality in Patients with Advanced Chronic Heart Failure Treated with Intermittent Low-Dose Intravenous Inotropes in an Outpatient SettingESC Heart Failure, 2016
- Minimal Clinically Important DifferenceJAMA, 2014
- Effects of Exercise Training on Health Status in Patients With Chronic Heart FailureJAMA, 2009
- Representation of the Elderly, Women, and Minorities in Heart Failure Clinical TrialsArchives of internal medicine (1960), 2002